Inhaled combination therapy with long-acting β2-agonists and corticosteroids in stable COPD
M Cazzola, R Dahl - Chest, 2004 - Elsevier
Long-acting β 2-agonists (LABAs) have been shown to be effective first-line bronchodilators
in the treatment of COPD patients, and inhaled corticosteroids (ICSs) have been shown to …
in the treatment of COPD patients, and inhaled corticosteroids (ICSs) have been shown to …
Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?
GP Currie, BJ Lipworth - QJM: An International Journal of …, 2016 - academic.oup.com
Since chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
obstruction, inhaled bronchodilators form the mainstay of treatment. A variety of new inhaled …
obstruction, inhaled bronchodilators form the mainstay of treatment. A variety of new inhaled …
Characteristics, disease burden and costs of COPD patients in the two years following initiation of long-acting bronchodilators in UK primary care
YS Punekar, SH Landis, K Wurst, H Le - Respiratory Research, 2015 - Springer
Background To assess the symptomatic and cost burden among patients initiating long-
acting bronchodilator (LABD) therapy and impact of adherence on healthcare resource use …
acting bronchodilator (LABD) therapy and impact of adherence on healthcare resource use …
Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
S Corrao, G Brunori, U Lupo… - European Respiratory …, 2017 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory
disease and its prevalence is increasing worldwide, in both industrialised and developing …
disease and its prevalence is increasing worldwide, in both industrialised and developing …
[HTML][HTML] Stepwise withdrawal of inhaled corticosteroids in COPD patients receiving dual bronchodilation: WISDOM study design and rationale
H Magnussen, H Watz, A Kirsten, M Decramer… - Respiratory …, 2014 - Elsevier
Long-acting bronchodilators in combination with inhaled corticosteroids (ICS) are
recommended to decrease the risk of recurrent exacerbations in patients with Global …
recommended to decrease the risk of recurrent exacerbations in patients with Global …
Long-acting bronchodilators are the first-choice option for the treatment of stable COPD
M Cazzola, MG Matera - Chest, 2004 - journal.chestnet.org
A volume of published evidence sustains the role of long-acting β2-agonists in the treatment
of stable COPD. 1–5 These agents not only induce prolonged bronchodilation, but also …
of stable COPD. 1–5 These agents not only induce prolonged bronchodilation, but also …
Treatment patterns for chronic obstructive pulmonary disease (COPD) in the United States: results from an observational cross-sectional physician and patient survey
D Mannino, J Siddall, M Small, A Haq… - … Journal of Chronic …, 2022 - Taylor & Francis
Purpose There is a high prevalence of chronic obstructive pulmonary disease (COPD) in the
United States (US). Although guidelines are available for the treatment of COPD, evidence …
United States (US). Although guidelines are available for the treatment of COPD, evidence …
The future of combining inhaled drugs for COPD
A Bjerg, B Lundbäck, J Lötvall - Current opinion in pharmacology, 2012 - Elsevier
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality
globally, and its prevalence is projected to continue to increase owing to trends in smoking …
globally, and its prevalence is projected to continue to increase owing to trends in smoking …
Withdrawal from treatment as an outcome in the ISOLDE study of COPD
PMA Calverley, S Spencer, L Willits, PS Burge… - Chest, 2003 - Elsevier
Objectives To investigate the determinants of patient withdrawal from our study, and the
effect of these withdrawals on the outcome of treatment with inhaled corticosteroids in …
effect of these withdrawals on the outcome of treatment with inhaled corticosteroids in …
Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators
NA Hanania, JF Donohue - Proceedings of the American Thoracic …, 2007 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is a treatable disease characterized by
progressive airflow limitation. Prevention of disease progression, improvement of symptoms …
progressive airflow limitation. Prevention of disease progression, improvement of symptoms …